MACROGENICS INC — Director's Dealing 2020

May 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2020-05-20

Reporting Person: Spitznagel Thomas (Sr VP, BPD & Manufacturing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-20	Common Stock	M	7500	$7.51	Acquired	7500	Direct
2020-05-20	Common Stock	S	7500	$25.30	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-20	Employee stock option (right to buy)	$7.51	M	7500	Disposed	2023-09-17	Common Stock (7500.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020.

F2: This transaction was executed in multiple trades at prices ranging from $24.86 to $25.78. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.